课题基金 / 基金详情

Bodytrak: early-detection of infectious diseases in industrial and front-line workers

Bodytrak: early-detection of infectious diseases in industrial and front-line workers
Bodytrak:早期发现工业和一线工人的传染病
批准号:
81094
负责人:
金额:
$22.01万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heat stress is a major issue for industrial workers operating in warm climates and/or wearing protective clothing (PPE). Economic costs due to heat illness are £504 on average per worker annually. At Inova, we developed Bodytrak(r), an innovative remote monitoring system used to acquire vital signs in real-time. From a small in-ear device, core body temperature and heart rate are continuously measured and transmitted to the Bodytrak cloud platform to display vital signs/alerts on a real-time dashboard.Covid-19 was declared a pandemic in March 2020 by WHO. The impact to industrial organisations, such as production plants, refineries, logistics and constructions firms has been a reduction in revenue due to economic slowdown, but also a reduction in productivity output due to cases of Covid-19 and the requirement for social distancing requiring fewer workers on site. Employers have to balance worker welfare with reducing economic impact and have been investing in technology which claims to provide early detection of Covid-19, e.g. thermal cameras, but MHRA reported that these products are not reliable since they measure skin temperature not CBT. Further, temperature alone is not adequate in providing a reliable assessment.This proposal seeks to expand the functionality of the Bodytrak in-ear solution to measure additional vital signs to automatically detect Covid-19 (and other infectious diseases), particularly for industrial and front-line workers who would wear the device routinely. The addressable market currently represents £8.35Bn globally (£476m UK) (2019), with growth rate 10-42%, and serviceable market £135m.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Crocin 抑制 Hartley 豚鼠早期骨关节炎发生的 作用机制研究
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
  • 批准号:
    82372167
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    江继宏
  • 依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
  • 批准号:
    82372089
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    李万万
  • 依托单位:
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
  • 批准号:
    82371605
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    蒋君涛
  • 依托单位: